Literature DB >> 11454723

The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression.

S W Allen1, L Mueller, S N Williams, L C Quattrochi, J Raucy.   

Abstract

We examined the effects of several agents, including dietary flavonoids, on CYP1A1 expression utilizing a recently developed high-throughput screening system for assessing human cytochrome P450 (CYP) induction. HepG2 cells, stably integrated with regulatory regions of human CYP1A1, were treated with resveratrol, apigenin, curcumin, kaempferol, green tea extract (GTE), (-)-epigallocatechin gallate (EGCG), quercetin, and naringenin. Of these flavonoids, resveratrol produced the greatest increase in CYP1A1-mediated luciferase activity (10-fold), whereas GTE, apigenin, curcumin, and kaempferol produced 2- to 3-fold increases in activity. Compared with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), omeprazole, or benzanthracene, where increases in luciferase activity ranged from 12- to 35-fold, these flavonoids exhibited weak agonist activity. The remaining compounds, EGCG, quercetin, and naringenin, produced negligible effects. Cotreatment of cells with TCDD and GTE, naringenin, and apigenin resulted in 58, 77, and 74% reductions, respectively, in TCDD-mediated CYP1A1 induction, indicating that these flavonoids exhibit potential antagonist activity toward the aryl hydrocarbon (Ah) receptor. Furthermore, results also suggest that GTE and apigenin possess Ah receptor antagonist and weak agonist activities. Thus, we have shown that a 96-well plate assay allowing high-throughput screening for P450 induction in less than 24 h was efficient in determining the effects of flavonoids on human CYP1A expression. Signal-to-noise ratios were low, and well-to-well and replicate variability was below 10%, allowing induction to be easily detected in this system. These features illustrate the reliability and feasibility of this high-volume screening system for identifying CYP inducers. Furthermore, results produced with the stable cell line were corroborated in HepG2 cells and primary cultures of human hepatocytes, suggesting that stably integrated cell lines harboring enhancer elements of P450 genes may be highly conducive to high-throughput screening.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454723

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

1.  Hydroxylated Chalcones as Aryl Hydrocarbon Receptor Agonists: Structure-Activity Effects.

Authors:  Hyejin Park; Un-Ho Jin; Keshav Karki; Clinton Allred; Laurie A Davidson; Robert S Chapkin; Asuka A Orr; Farrhin Nowshad; Arul Jayaraman; Phanourios Tamamis; Stephen Safe
Journal:  Toxicol Sci       Date:  2021-02-26       Impact factor: 4.849

2.  Assessment of compound hepatotoxicity using human plateable cryopreserved hepatocytes in a 1536-well-plate format.

Authors:  Timothy A Moeller; Sunita J Shukla; Menghang Xia
Journal:  Assay Drug Dev Technol       Date:  2011-11-04       Impact factor: 1.738

3.  Fourteen-week toxicity study of green tea extract in rats and mice.

Authors:  Po C Chan; Yuval Ramot; David E Malarkey; Pamela Blackshear; Grace E Kissling; Greg Travlos; Abraham Nyska
Journal:  Toxicol Pathol       Date:  2010-09-30       Impact factor: 1.902

4.  Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells.

Authors:  U Stervbo; O Vang; C Bonnesen
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

5.  Characteristics and application of established luciferase hepatoma cell line that responds to dioxin-like chemicals.

Authors:  Zhi-Ren Zhang; Shun-Qing Xu; Xi Sun; Yong-Jun Xu; Xiao-Kun Cai; Zhi-Wei Liu; Xiang-Lin Tan; Yi-Kai Zhou; Jun-Yue Zhang; Hong Yan
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

6.  Structure-Dependent Modulation of Aryl Hydrocarbon Receptor-Mediated Activities by Flavonoids.

Authors:  Un-Ho Jin; Hyejin Park; Xi Li; Laurie A Davidson; Clinton Allred; Bhimanagouda Patil; Guddadarangavva Jayaprakasha; Asuka A Orr; Leevin Mao; Robert S Chapkin; Arul Jayaraman; Phanourios Tamamis; Stephen Safe
Journal:  Toxicol Sci       Date:  2018-07-01       Impact factor: 4.849

7.  Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro.

Authors:  Junli Hong; Adryan Fristiohady; Chi H Nguyen; Daniela Milovanovic; Nicole Huttary; Sigurd Krieger; Junqiang Hong; Silvana Geleff; Peter Birner; Walter Jäger; Ali Özmen; Liselotte Krenn; Georg Krupitza
Journal:  Front Pharmacol       Date:  2018-03-14       Impact factor: 5.810

8.  Nano-fibre Integrated Microcapsules: A Nano-in-Micro Platform for 3D Cell Culture.

Authors:  Shalil Khanal; Shanta R Bhattarai; Jagannathan Sankar; Ramji K Bhandari; Jeffrey M Macdonald; Narayan Bhattarai
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

Review 9.  Key factors which concur to the correct therapeutic evaluation of herbal products in free radical-induced diseases.

Authors:  Cesare Mancuso
Journal:  Front Pharmacol       Date:  2015-04-22       Impact factor: 5.810

10.  Hop (Humulus lupulus L.) Extract and 6-Prenylnaringenin Induce P450 1A1 Catalyzed Estrogen 2-Hydroxylation.

Authors:  Shuai Wang; Tareisha L Dunlap; Caitlin E Howell; Obinna C Mbachu; Emily A Rue; Rasika Phansalkar; Shao-Nong Chen; Guido F Pauli; Birgit M Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2016-06-22       Impact factor: 3.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.